EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Phenotype and genotype of autosomal dominant tubulointerstitial kidney disease in a Japanese cohort

Yu Tanaka, China Nagano, Nana Sakakibara, Eri Okada, Shuhei Aoyama, Yuka Kimura, Yuta Inoki, Yuta Ichikawa, Chika Ueda, Hideaki Kitakado, Tomoko Horinouchi, Tomohiko Yamamura und 4 weitere

Clinical and Experimental Nephrology · 2025-06 · 29 (6) · 788-796

DOI: 10.1007/s10157-025-02629-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Nephrology, online erschienen am 20.02.2025. Verfasst von Yu Tanaka und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-Cho, Chuo-Ku, Kobe, Hyogo, 650-0017, Japan. Hauptthemen laut MEDLINE: Nephritis, Interstitial, Polycystic Kidney, Autosomal Dominant, East Asian People. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: H24-nanchi-ippan, H29-nanchi-ippan, 23FC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Autosomal dominant tubulointerstitial kidney disease (ADTKD) is characterized by tubular atrophy, interstitial fibrosis, and progressive kidney dysfunction. Its causative genes include UMOD, MUC1, REN, HNF1B , and SEC61A1 . ADTKD contributes to unexplained chronic kidney disease (CKD), and many cases remain genetically undiagnosed. This study aimed to elucidate the clinical features of patients genetically diagnosed with ADTKD in Japan.

Methods

We included individuals with suspected congenital anomalies of the kidney and urinary tract, nephronophthisis, polycystic kidney disease, or ADTKD. Genetic analyses using direct sequencing, short-read next-generation sequencing (SRS), and/or long-read next-generation sequencing (LRS) were performed on 1097 families. Patients with ADTKD– HNF1B were excluded due to prior reporting.

Results

Variants in UMOD, MUC1, REN, and SEC61A1 were identified in 52 patients from 40 families (18, 16, 5, and 1 family, respectively). The median age at diagnosis was 38.5 years, and the urinary protein-to-creatinine ratio was 0.05 g/gCr. End-stage kidney disease was present at diagnosis in 37% of patients. Genetic testing was performed in 58% due to suspected ADTKD based on pathology or clinical course and in 38% due to unexplained CKD. Kidney biopsies were performed in 55%, with ADTKD confirmed pathologically in 41%. SRS and LRS were used in 55% and 30% of all families, respectively; for ADTKD– MUC1, 75% of families were analyzed using LRS.

Conclusions

Clinical and pathological diagnosis of ADTKD remains challenging, emphasizing the importance of comprehensive genetic testing. Enhanced access to advanced genetic testing such as LRS is essential to improve diagnostic precision and management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nephritis, InterstitialPolycystic Kidney, Autosomal DominantEast Asian PeopleAdolescentAdultAgedChildFemaleHumansMaleMiddle AgedYoung AdultGenetic Predisposition to DiseaseGenetic TestingGenotypeJapanMucin-1MutationPedigreePhenotypeUromodulin

Stichwörter der Autor:innen

MUC1RENSEC61A1UMODAutosomal dominant tubulointerstitial kidney diseaseChronic kidney disease

Substanzen

MUC1 protein, humanMucin-1UMOD protein, humanUromodulin

Autor:innen und Institutionen

  • Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-Cho, Chuo-Ku, Kobe, Hyogo, 650-0017, Japan.
  • Hyogo Prefectural Kobe Children's Hospital, 1-6-7, Minatojimaminami-Machi, Chuo-Ku, Kobe, Hyogo, 650-0047, Japan.
  • Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-Cho, Chuo-Ku, Kobe, Hyogo, 650-0017, Japan. morisada_kch@hp.pref.hyogo.jp.
  • Department of Clinical Genetics, Hyogo Prefectural Kobe Children's Hospital, 1-6-7, Minatojimaminami-Machi, Chuo-Ku, Kobe, Hyogo, 650-0047, Japan. morisada_kch@hp.pref.hyogo.jp.

Förderung

  • H24-nanchi-ippan
  • H29-nanchi-ippan
  • 23FC
  • KAKENHI
  • the Japan Agency for Medical Research and Development

Zitieren

APA

Tanaka, Y., Nagano, C., Sakakibara, N., Okada, E., Aoyama, S., Kimura, Y., Inoki, Y., Ichikawa, Y., Ueda, C., Kitakado, H., Horinouchi, T., Yamamura, T., Ishimori, S., Iijima, K., Nozu, K., & Morisada, N. (2025). Phenotype and genotype of autosomal dominant tubulointerstitial kidney disease in a Japanese cohort. Clinical and Experimental Nephrology, 29(6), 788-796. https://doi.org/10.1007/s10157-025-02629-4

Vancouver

Tanaka Y, Nagano C, Sakakibara N, Okada E, Aoyama S, Kimura Y, et al. Phenotype and genotype of autosomal dominant tubulointerstitial kidney disease in a Japanese cohort. Clinical and Experimental Nephrology. 2025;29(6):788-796. doi:10.1007/s10157-025-02629-4

BibTeX
@article{Tanaka2025,
  author = {Tanaka, Yu and Nagano, China and Sakakibara, Nana and Okada, Eri and Aoyama, Shuhei and Kimura, Yuka and Inoki, Yuta and Ichikawa, Yuta and Ueda, Chika and Kitakado, Hideaki and Horinouchi, Tomoko and Yamamura, Tomohiko and Ishimori, Shingo and Iijima, Kazumoto and Nozu, Kandai and Morisada, Naoya},
  title = {Phenotype and genotype of autosomal dominant tubulointerstitial kidney disease in a Japanese cohort},
  journal = {Clinical and Experimental Nephrology},
  year = {2025},
  volume = {29},
  number = {6},
  pages = {788--796},
  doi = {10.1007/s10157-025-02629-4}
}
Kostenlos starten →